Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Arnaldez Website

Fernanda I. Arnaldez, M.D.

Portait Photo of Fernanda Arnaldez
Pediatric Oncology Branch
Molecular Oncology Section
Assistant Clinical Investigator
Center for Cancer Research
National Cancer Institute
Building 10 - Hatfield Clinical Research Center
Room 1-3816
Bethesda, MD 20892


Fernanda Arnaldez was born in Buenos Aires, Argentina. She attended University of Buenos Aires School of Medicine where she graduated with honors. She completed her Pediatric Residency in Argentina (Ricardo Gutierrez Children's Hospital) and then joined the Pediatric Residency Program at University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania, where she distinguished herself for her excellence in patient care and medical education. She joined the Pediatric Hematology-Oncology Clinical Fellow in the Johns Hopkins/NIH Fellowship Training Program where she served as Chief Fellow in 2010. After completing the Advanced Solid Tumor Oncology Training Program, she joined the CCR as an Assistant Clinical Investigator in 2012. Dr. Arnaldez is Board Certified in General Pediatrics and in Pediatric Hematology/Oncology.


Dr. Arnaldez focuses on molecular oncology research in the section led by Dr. Lee J. Helman. She works on understanding signaling pathways involved in the biology of alveolar rhabdomyosarcoma in order to improve the outcome of patients affected by this tumor. Her goal is to identify the molecular determinants of rhabdomyosarcoma biology in order to apply this knowledge to develop novel targeted therapies. In addition, she is developing therapeutic approaches for patients with wild-type gastrointestinal stromal tumors. Her work has been widely recognized. She has received Young Investigator Awards from ASCO (Conquer Cancer Foundation), Alex's Lemonade Stand Foundation and Children's Cancer Foundation. She has also received awards from the American Society of Pediatric Hematology-Oncology and the Pediatric Academic Societies.

This page was last updated on 5/22/2014.